Biological Activity and Delivery of Peptide Nucleic Acids (PNA)-DNA Chimeras for Transcription Factor Decoy (TFD) Pharmacotherapy

Author(s): Roberto Gambari

Journal Name: Current Medicinal Chemistry

Volume 11 , Issue 10 , 2004

Become EABM
Become Reviewer
Call for Editor


Peptide nucleic acids (PNAs) are recently described DNA mimics, in which the sugar-phosphate backbone is replaced by N-(2-aminoethyl)glycine units. These molecules efficiently hybridize with complementary DNA, forming Watson-Crick double helices. In addition, the interest of PNAs and PNA-based analogs is related to the fact that they are resistant to DNases and proteinases. While applications of PNAs as antisense and antigéne molecules in non-viral gene therapy are well documented, their effects as potential transcription factor decoy (TFD) molecules is not demonstrated. PNA / PNA and PNA / DNA duplex are not suitable for TFD. In fact, PNA / PNA duplex does not recognize transcription factors, while, in the case of PNA / DNA hybrids containing nuclear factor binding sites, the interaction with transcription factors is unstable. By sharp contrast, double stranded molecules based on PNADNA chimeras exhibit strong TFD activity, display enzymatic stability in serum and cellular extracts and can be delivered to target cells after complexation with liposomes and microspheres. The TFD molecules based on PNA-DNA chimeras can be further engineered by addition of short peptides facilitating cell penetration and nuclear localization. Therefore, these engineered molecules could be of great interest for in vivo experiments on non-viral gene therapy of a variety of diseases, including neoplastic and viral diseases, for which the TFD approach has been already demonstrated as a very useful strategy.

Keywords: transcription, decoy, delivery, gene therapy, peptide-nucleic acids, pna-dna chimeras

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2004
Page: [1253 - 1263]
Pages: 11
DOI: 10.2174/0929867043365242
Price: $65

Article Metrics

PDF: 5